Literature DB >> 15882627

Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.

Konrad Hochedlinger1, Yasuhiro Yamada, Caroline Beard, Rudolf Jaenisch.   

Abstract

The POU-domain transcription factor Oct-4 is normally expressed in pluripotent cells of the mammalian embryo. In addition, germ-cell tumors and a few somatic tumors show detectable expression of Oct-4. While Oct-4's role during preimplantation development is to maintain embryonic cells in a pluripotent state, little is known about its potential oncogenic properties. Here we investigate the effect of ectopic Oct-4 expression on somatic tissues of adult mice using a doxycycline-dependent expression system. Activation of Oct-4 results in dysplastic growths in epithelial tissues that are dependent on continuous Oct-4 expression. Dysplastic lesions show an expansion of progenitor cells and increased beta-catenin transcriptional activity. In the intestine, Oct-4 expression causes dysplasia by inhibiting cellular differentiation in a manner similar to that in embryonic cells. These data show that certain adult progenitors remain competent to interpret key embryonic signals and support the notion that progenitor cells are a driving force in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882627     DOI: 10.1016/j.cell.2005.02.018

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  388 in total

1.  Depot formation of doxycycline impairs Tet-regulated gene expression in vivo.

Authors:  Kathleen Anders; Christian Buschow; Jehad Charo; Thomas Blankenstein
Journal:  Transgenic Res       Date:  2011-12-14       Impact factor: 2.788

2.  Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature.

Authors:  Huansheng Xu; B Alexander Yi; Hao Wu; Christoph Bock; Hongcang Gu; Kathy O Lui; Joo-Hye C Park; Ying Shao; Alyssa K Riley; Ibrahim J Domian; Erding Hu; Robert Willette; John Lepore; Alexander Meissner; Zhong Wang; Kenneth R Chien
Journal:  Cell Res       Date:  2011-11-08       Impact factor: 25.617

3.  Oct-3/4 regulates stem cell identity and cell fate decisions by modulating Wnt/β-catenin signalling.

Authors:  Monther Abu-Remaileh; Ariela Gerson; Marganit Farago; Gili Nathan; Irit Alkalay; Sharon Zins Rousso; Michal Gur; Abraham Fainsod; Yehudit Bergman
Journal:  EMBO J       Date:  2010-08-24       Impact factor: 11.598

4.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

Authors:  Marie Zbinden; Arnaud Duquet; Aiala Lorente-Trigos; Sandra-Nadia Ngwabyt; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

5.  Klf5 regulates lineage formation in the pre-implantation mouse embryo.

Authors:  Suh-Chin J Lin; Maqsood A Wani; Jeffrey A Whitsett; James M Wells
Journal:  Development       Date:  2010-10-27       Impact factor: 6.868

6.  An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.

Authors:  Joan P Breyer; Daniel C Dorset; Travis A Clark; Kevin M Bradley; Tiina A Wahlfors; Kate M McReynolds; William H Maynard; Sam S Chang; Michael S Cookson; Joseph A Smith; Johanna Schleutker; William D Dupont; Jeffrey R Smith
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

7.  Suppression of intestinal neoplasia by deletion of Dnmt3b.

Authors:  Haijiang Lin; Yasuhiro Yamada; Suzanne Nguyen; Heinz Linhart; Laurie Jackson-Grusby; Alexander Meissner; Konstantinos Meletis; Grace Lo; Rudolf Jaenisch
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Cyclin B2 and p53 control proper timing of centrosome separation.

Authors:  Hyun-Ja Nam; Jan M van Deursen
Journal:  Nat Cell Biol       Date:  2014-04-28       Impact factor: 28.824

9.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

10.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.